Shopping Cart
- Remove All
- Your shopping cart is currently empty
Golimumab (CNTO-148) is a potent humanized anti-TNFα IgG1κ monoclonal antibody with anti-inflammatory and anticancer activity. It inhibits the production of IL-6 and IL-1β, induces apoptosis, and can be used to prevent inflammation and destruction of cartilage or bone. This makes Golimumab valuable for studying rheumatoid arthritis and cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $243 | In Stock | |
5 mg | $562 | In Stock | |
10 mg | $783 | In Stock | |
25 mg | $1,190 | In Stock | |
50 mg | $1,590 | In Stock |
Description | Golimumab (CNTO-148) is a potent humanized anti-TNFα IgG1κ monoclonal antibody with anti-inflammatory and anticancer activity. It inhibits the production of IL-6 and IL-1β, induces apoptosis, and can be used to prevent inflammation and destruction of cartilage or bone. This makes Golimumab valuable for studying rheumatoid arthritis and cancer. |
In vitro | Inducing reductions in the viability of transmembrane TNFα–expressing cells, Golimumab (CNTO-148) (0.1-10 μg/mL; 24-72 hours; transmembrane TNFα–transfected Jurkat cells) [1].Inducing apoptosis, increasing the levels of active caspase-3, and inducing apoptotic DNA fragmentation, Golimumab (CNTO-148) (10 μg/mL; 48 hours; transmembrane TNFα–transfected Jurkat cells) [1]. |
In vivo | Golimumab (CNTO-148), administered intraperitoneally at doses of 1-10 mg/kg daily for 4 weeks in the Tg197 transgenic mouse model, relieves TNFα-induced arthritis in a mouse model of humans [3].Golimumab (CNTO-148), administered intravenously at a dose of 24 mg/kg daily for 7 days in Swiss-albino healthy male mice, inhibits oxidative stress, apoptotic cell death, and inflammatory response, thereby improving renal function. Golimumab reduces all markers of kidney injury and attenuates cell death [3]. |
Alias | SCH 900259, MK-8259, CNTO-148 |
Molecular Weight | 146.93 kDa |
Cas No. | 476181-74-5 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.